A highly sensitive and rapid LC-MS/MS method for quantification of bexarotene in mouse plasma and brain tissue: Application to mice pharmacokinetic study

• Published in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 1189; p. 123025
• Main Authors: Fu, Huimei, Chu, Lijuan, Jiao, He, Lin, Longyi, Liu, Youping, Chen, Guoliang, Zou, Libo, Wang, Xin, Di, Xin
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.01.2022
• Subjects: Animals; Bexarotene; Bexarotene - analysis; Bexarotene - chemistry; Bexarotene - pharmacokinetics; Brain Chemistry - physiology; Brain tissue; Chromatography, Liquid - methods; LC–MS/MS; Limit of Detection; Linear Models; Mice; Mice, Inbred C57BL; Mouse; Pharmacokinetics; Plasma; Reproducibility of Results; Tandem Mass Spectrometry - methods; Plasma; LLOQ; Bexarotene; RSD; AD; CNS; IS; LC–MS/MS; Brain tissue; SRM; QC; RE; Mouse; MF; ESI; Pharmacokinetics
• ISSN: 1570-0232; 1873-376X
• DOI: 10.1016/j.jchromb.2021.123025

[Display omitted] •First report for quantification of bexarotene in biological matrix by LC–MS/MS.•LLOQ of 10.0 ng/mL was achieved with consumption of only 20 μL of plasma or tissue homogenate.•Simple sample pretreatment with a single-step protein precipitation method was employed.•First investigation of bexarotene pharmacokinetics in mice using a fully validated LC–MS/MS method. Emerging evidence has suggested that bexarotene, a nearly 20-year-old skin cancer drug, may be a potential drug candidate to treat Alzheimer's disease (AD) and other neurodegenerative disorders. As described in this study, a highly sensitive and rapid method, using liquid chromatography–tandem mass spectrometry (LC–MS/MS) to determine bexarotene in mouse plasma and brain tissue, was established and validated for the first time. Single-step protein precipitation utilizing methanol solution (containing 0.05 % acetic acid) as precipitation agent was employed to prepare the samples of plasma and brain tissue. Chromatographic separation in gradient elution mode was conducted via an Agilent ZORBAX SB-C18 column (50 mm × 4.6 mm, 5 µm) employing methanol–ammonium acetate buffer (5 mM, pH adjusted to 4.6 with acetic acid) as mobile phase which flowed at 0.45 mL/min. The total run time was 6 min for each sample. Detection through mass spectrometric technique was operated by selected reaction monitoring (SRM) in negative electrospray ionization mode. The method was linear within the range of 10.0–15000 ng/mL for plasma and 10.0–600 ng/mL for brain tissue homogenate with the lower limit of quantification of 10.0 ng/ml. The plasma or tissue homogenate was only required 20 μL. The intra- and inter-day precision were less than 13.8 %, and the RE was between –7.4 % and 3.4 %. The method was applied to investigate the plasma pharmacokinetics and brain distribution of bexarotene in mice after being intragastrically administered with bexarotene at the dosage of 100 mg/kg. The results showed that both brain and plasma concentrations of bexarotene peaked at 1.0 h. Bexarotene was rapidly eliminated with a half-life of 2.0 h.